ArticleMolecules (Basel, Switzerland)2022
Design, Synthesis, and Evaluation of New Mesenchymal-Epithelial Transition Factor (c-Met) Kinase Inhibitors with Dual Chiral Centers.
Han Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.